Information about the rules and regulations that govern interactions between pharmaceutical, bioscience, medical device company, and other life sciences company interactions with physicians and other healthcare professionals. This includes information on the Sunshine Act, state laws, the PhRMA Code, and the AdvaMed Code on Ethical Interactions with Healthcare Professionals.
The Food and Drug Administration recently announced in the Federal Register that it has released its draft "Blueprint for Prescriber Continuing Education Program.” The blueprint is designed to guide continuing medical education providers as they...
Stefan Schneeberger, M.D., an Austrian transplant surgeon, spoke about the benefits of live medical meetings at a recent conference that garnered opinions from a variety of stakeholders about the future of global meetings, both live and virtual...
Pharma and life sciences meetings are essential for business, but meeting managers must be careful about compliance if they want to mitigate regulatory risks. This wrap-up from our annual forum will show you how.
The Massachusetts House of Representatives has voted 128-22 to repeal the Massachusetts Pharmaceutical and Medical Device Manufacturer Code of Conduct. The April 26 vote was the second time in two years the House voted to repeal the 2008 law...
It took me forever to get around to posting this, but speaker and productivity expert Neen James took a few minutes at this year's Pharmaceutical Meeting Management Forum to share a quick tip:
Thanks, Neen!
